Summary of Analysis on NK-TCL and PTLD
| Lymphoma . | No. of Cases . | MSI . | Donor Origin . | Host Origin . |
|---|---|---|---|---|
| NK-TCL | ||||
| Allograft recipient | 3 | 1 | 1 | 2 |
| Immunocompetent | 3 | 0 | NA | NA |
| All PTLD | ||||
| Cases studied for MSI | 9 | 2 | NA | NA |
| Cases studied for donor/host origin | 39 | NA | 7 | 32 |
| Lymphoma . | No. of Cases . | MSI . | Donor Origin . | Host Origin . |
|---|---|---|---|---|
| NK-TCL | ||||
| Allograft recipient | 3 | 1 | 1 | 2 |
| Immunocompetent | 3 | 0 | NA | NA |
| All PTLD | ||||
| Cases studied for MSI | 9 | 2 | NA | NA |
| Cases studied for donor/host origin | 39 | NA | 7 | 32 |
Abbreviations: NK-TCL, Natural killer–like T-cell lymphoma; PTLD, posttransplant lymphoproliferative disorder; MSI, microsatellite instability; NA, not applicable.